AI in Validation · Governance

AI in Pharmaceutical Validation: Governance, Human Review and Data Integrity

AI can accelerate validation drafting, comparison, classification and analysis, but regulated organizations remain accountable for the accuracy, suitability and approval of every validation record. A defensible model combines controlled inputs, transparent review, traceability and qualified human decisions.

By Mohammad Awawdeh · Published and reviewed 1 September 2026

Where AI can add value

Useful applications include structuring first drafts, suggesting requirement categories, identifying missing links, comparing document versions, summarizing evidence and supporting consistency checks. These activities can reduce repetitive work and help reviewers focus on risk and technical judgement.

The value is greatest when AI operates inside a controlled workflow rather than as an unrecorded external conversation.

What AI should not decide alone

AI should not independently approve requirements, determine product impact, close deviations, accept failed tests or release a system for GxP use. Those decisions require accountable personnel who understand intended use, evidence, risk and the company’s quality system.

Generated output must be treated as draft content until it is reviewed, corrected where necessary and formally approved.

Governance controls to establish

Define approved use cases, prohibited data, user roles, input and output review, record retention, change management, supplier oversight, model update assessment and escalation of unreliable output. Training should address both effective use and the risk of automation bias.

Validation should focus on intended use and the controls that make AI-supported activities predictable, reviewable and suitable for the regulated process.

Controlled AI support in PHARPRO DVS

PHARPRO DVS uses built-in drafting intelligence within connected validation workflows. Project context, traceability, review and approval remain part of the controlled lifecycle, and qualified users retain responsibility for every approved record.

This is different from copying regulated information into an uncontrolled public tool and manually moving the result back into a document.

Frequently asked questions

Can AI write validation documents?

AI can support structured first drafts, but qualified users must verify technical accuracy, completeness and suitability before approval.

Is AI output automatically a GxP record?

That depends on intended use and the approved process. Organizations should define when inputs, outputs and review evidence become regulated records.

How should model changes be handled?

Assess whether the change can affect intended use, output behavior or validated controls, then apply risk-based testing and change control.

See PHARPRO DVS in action

Explore connected validation documents, requirements traceability, controlled review and AI-assisted drafting with qualified human approval.

Explore PHARPRO DVS & book a demo →